Studies on the basis for the toxicity of acrolein mercapturates

Toxicology and Applied Pharmacology

Volumn 140, Issue 2, 1996, Pages 487-498

  Ramu, Kumar ^a,b   Perry, Camarie S ^a,c   Ahmed, Tamer ^a   Pakenham, Gwyn ^a   Kehrer, James P ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b Department of Pharmacokinetics and Drug Metabolism   (United States)

^c Texas Nat Rsrc Conserv Commission   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN DERIVATIVE; CYCLOPHOSPHAMIDE; GLUTATHIONE; THIOL DERIVATIVE;

ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG ADENOMA; LUNG TOXICITY;

EID: 0030273743     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0245     Document Type: Article

References (48)

1. Adams, J. D., and Klaidman, L. K. (1993). Acrolein-induced oxygen radical formation. Free Radical Biol. Med. 15, 187-193.
2. Alarcon, R. A. (1976). Studies on the in vivo formation of acrolein: 3-Hydroxypropylmercapturic acid as an index of cyclophosphamide activation. Cancer Treatment Rep. 60, 327-335.
3. Black, K. A., and Finch, L. (1995). Acrylic acid oxidation and tissue-to-blood partition coefficients in rat tissues. Toxicol. Lett. 78, 73-78.
4. Black, K. A., Beskitt, J. L., Finch, L., Tallant, M. J., Udinsky, J. R., and Frantz, S. W. (1995). Disposition and metabolism of acrylic acid in C3H mice and Fischer 344 rats after oral or cutaneous administration. J. Toxicol. Environ. Health 45, 291-311.
5. Boor, P. J., and Ansari, G. A. S. (1986). High-performance liquid Chromatographic method for quantitation of acrolein in biological samples. J. Chromatogr. Biomed. Appl. 375, 159-164.
6. Bradford, M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein. Anal. Biochem. 72, 248-254.
7. Brock, N., and Pohl, J. (1986). Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazophosphorine cystostatics. IARC Sci. Publ. 78, 269-279.
8. Chang, K. K., Hong, P. S., Tutsch, K., and Trump, D. L. (1994). Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508. Cancer Res. 54, 6421-6429.
9. Cox, P. J. (1979). Cyclophosphamide cystitis - Identification of acrolein as the causative agent. Biochem. Pharmacol. 28, 2045-2049.
10. DeBethizy, J. D., Udinsky, J. R., Scribner, H. E., and Frederick, C. B. (1987). The disposition and metabolism of acrylic acid and ethyl acrylate in male sprague-dawley rats. Fundam. Appl. Toxicol. 8, 549-561.
11. Delbressine, L. P. C., Seutter-Berlage, F., and Seutter, E. (1981a). Identification of urinary mercapturic acids formed from acrylate, methacrylate and crotonate in the rat. Xenobiotica 11, 241-247.
12. Delbressine, L. P. C., Klippert, P. J. M., Reuvers, J. T. A., and Seutter-Berlage, F. (1981b). Isolation and identification of mercapturic acids of cinnamic aldehyde and cinnamyl alcohol from urine of female rats. Arch. Toxicol. 49, 57-64.
13. Deneke, S. M., and Fanburg, B. L. (1989). Regulation of cellular glutathione. Am. J. Physiol. 257, L163-L173.
14. Draminski, W., Eder, E., and Henschler, D. (1983). A new pathway of acrolein metabolism in rats. Arch. Toxicol. 52, 243-247.
15. Esterbauer, H., Zollner, H., and Scholz, N. (1975). Reaction of glutathione with conjugate carbonyls. Z. Naturforsch. 39, 466-473.
16. Esterbauer, H., Eartl, A., and Scholz, N. (1976). The reaction of cysteine with ab-unsaturated aldehydes. Tetrahedron 32, 285-289.
17. 13C nuclear magnetic resonance spectroscopy. Chem. Res. Toxicol. 4, 678-687.
18. Fraiser, L. H., and Kehrer, J. P. (1992). Murine strain differences in metabolism and bladder toxicity of cyclophosphamide. Toxicology 75, 257-272.
19. Fraiser, L. H., and Kehrer, J. P. (1993). Effect of indomethacin, aspirin, nordihydroguairetic acid, and piperonyl butoxide on cyclophosphamide-induced bladder damage. Drug Chem. Toxicol. 16, 117-133.
20. Fraiser, L. H., Kanekal, S., and Kehrer, J. P. (1991). Cyclophosphamide toxicity. Drugs 42, 781-795.
21. Gurtoo, H. L., Hipkens, J. H., and Sharma, S. D. (1981). Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res. 41, 3584-3591.
22. Hashmi, M., Vamvakas, S., and Anders, M. W. (1992). Bioactivation mechanism of S-(3 oxopropyl)-N-acetyl-L-cysteine, the mercapturic acid of acrolein. Chem. Res. Toxicol. 5, 360-365.
23. Hipkens, J. H., Struck, R. F., and Gurtoo, H. L. (1981). Role of aldehyde dehydrogenase in the metabolism-dependent biological activity of cyclophosphamide. Cancer Res. 41, 3571-3583.
24. Hong, P. S., Srigritsanapol, A., and Chan, K. K. (1991). Pharmacokinetics of 4-hydroxycyclophosphamide and metabolites in the rat. Drug Metab. Dispos. 19, 1-7.
25. Horvath, J. J., Witmer, C. M., and Witz, G. (1992). Nephrotoxicity of the 1:1 acrolein-glutathione adduct in the rat. Toxicol. Appl. Pharmacol. 117, 1-8.
26. Itzhaki, R. F., and Gill, D. M. (1964). A micro-biuret method for estimating proteins. Anal. Biochem. 9, 401-410.
27. Kachel, D. L., and Martin, W. J. (1994). Cyclophosphamide-induced lung toxicity: Mechanism of endothelial cell. J. Pharmacol. Exp. Ther. 268, 42-46.
28. Kang, Y. J., and Enger, M. D. (1990). Glutathione content and growth in A549 human lung carcinoma cells. Exp. Cell Res. 187, 177-179.
29. Kang, Y. J., Feng, Y., and Hatcher, E. L. (1994). Glutathione stimulates A549 cell proliferation in glutamine-deficient culture: The effect of glutamate supplementation. J. Cell. Physiol. 161, 589-596.
30. Lash, L. H., and Woods, E. B. (1991). Cytotoxicity of alkylating agents in isolated rat kidney proximal tubular and distal tubular cells. Arch. Biochem. Biophys. 286, 46-56.
31. Lee, F. Y. F. (1991). Glutathione diminishes the anti-tumor activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites. Br. J. Cancer 63, 45-50.
32. Levine, L. A., and Richie, J. P. (1989). Urological complications of cyclophosphamide. J. Urol. 141, 1063-1067.
33. Mitchell, D. B., Santone, K. S., and Acosta, D. (1980). J. Tissue Culture Methods 6, 113-116.
34. Neuschwander-Tetri, B. A., and Roll, F. J. (1989). Glutathione measurement by high-performance liquid chromatography separation and fluorometric detection of the glutathione-orthophthalaldehyde adduct. Anal. Biochem. 179, 236-241.
35. Newton, G. L., Aguilera, J. A., Fahey, R. C., Ward, J. F., Radkowsky, A. E., and Kosower, E. M. (1992). para-Sulfobenzoyloxybromobimane: A new membrane-impermable reagent useful for the analysis of thiols and their export from cells. Anal. Biochem. 201, 30-42.
36. Ohno, Y., and Ormstad, K. (1985). Formation, toxicity and inactivation of acrolein during biotransformation of cyclophosphamide as studied in freshly isolated cells from rat liver and kidney. Arch. Toxicol. 57, 99-103.
37. Patel, J. M. (1990). Metabolism and pulmonary toxicity of cyclophosphamide. Pharmacol. Ther. 47, 137-146.
38. Patel, J. M., Wood, J. C., and Leibman, K. C. (1980). The biotransformation of allyl alcohol and acrolein in rat liver and lung preparations. Drug Metab. Dispos. 8, 305-308.
39. Perry, C. S., Liu, X., Lund, L. G., Whitman, C. P., and Kehrer, J. P. (1995). Differential toxicities of cyclophosphamide and its glutathione metabolites to A549 cells. Toxicol. in Vitro 9, 21-26.
40. Ramu, K., Fraiser, L. H., Mamiya, B., Ahmed, T., and Kehrer, J. P. (1995). Acrolein mercapturates: Synthesis, characteriztion, and assessment of their role in the bladder toxicity of cyclophosphamide. Chem. Res. Toxicol. 8, 515-524.
41. Rikans, L. E. (1987). The oxidation of acrolein by rat liver aldehyde dehydrogenases. Drug Metab. Dispos. 15, 356-362.
42. Sanduja, R., Ansari, G. A. S., and Boor, P. J. (1989). 3-Hydroxypropylmercapturic acid: A biologic marker of exposure to allylic and related compounds. J. Appl. Toxicol. 9, 235-238.
43. Sladek, N. E. (1971). Metabolism of cyclophosphamide by rat hepatic microsomes. Cancer Res. 31, 901-908.
44. Sladek, N. E. (1988). Metabolism of oxazaphosphorines. Pharmacol. Ther. 37, 301-355.
45. Sladek, N. E., Smith, P. C., Bratt, P. M., Low, J. E., Powers, J. F., Borch, R. F., and Coveney, J. R. (1982). Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity. Cancer Treatment Rep. 66, 1889-1900.
46. Tietze, F. (1969). Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal. Biochem. 27, 502-522.
47. 13C nuclear magnetic resonance spectroscopy. Drug Metab. Dispos. 20, 665-672.
48. Wlodek, L. (1988). The reaction of sulfhydryl groups with carbonyl compounds. Acta Bioch. Polonica 4, 307-317.